Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of OMS302 in Cataract Surgery
NCT01193127Phase 2Completed
- Sponsor
- Omeros Corporation
- Start
- Jul 2010
- Primary completion
- Jan 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of phenylephrine + ketorolac in cataract (4 arms), sponsored by Omeros Corporation. Primary endpoints: Pupil Diameter During Surgery and Ocular Pain Visual Analog Scale Score. Started Jul 2010; status: completed.
02
Drugs
phenylephrine + ketorolac
03
Conditions
cataract
Beyond the preview
Go deeper on NCT01193127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193127.